Well Told Grants

Federal grant programs / Allergy and Infectious Diseases Research

Allergy and Infectious Diseases Research in Nebraska

Allergy and Infectious Diseases Research (93.855) awarded $60.1 million to recipients in Nebraska in 58 grants from fiscal 2021 to 2025, 0.3% of the program's national total. Board of Regents of the University of Nebraska received the most, $47.9 million.

By year

Grants under this program to recipients in Nebraska
Fiscal yearAwardsAmount
FY 202126$12.4 million
FY 202228$16.5 million
FY 202324$11.9 million
FY 202424$9.3 million
FY 202523$10.0 million

Recipients in Nebraska

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
Board of Regents of the University of NebraskaColleges and universities40$47.9 million
Board of Regents of the University of NebraskaColleges and universities8$8.7 million
Creighton UniversityColleges and universities9$3.1 million
University of NebraskaColleges and universities1$371,250

Counted by the recipient's location. A recipient based in Nebraska may carry out the work elsewhere.

Open opportunities under this program

See all 93 on the program page

Questions people ask

How much Allergy and Infectious Diseases Research money goes to Nebraska?

$60.1 million from fiscal 2021 to 2025, across 58 awards. Nebraska ranks 35th of 52 states and territories for this program.

Who receives Allergy and Infectious Diseases Research money in Nebraska?

The largest recipient is Board of Regents of the University of Nebraska, with $47.9 million in 40 awards. Next are Board of Regents of the University of Nebraska and Creighton University.

Can organizations in Nebraska apply now?

Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Allergy and Infectious Diseases Research in other states

Other large programs in Nebraska

All federal grants in Nebraska

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.